Cvs Health (CVS) Capital Expenditures (2009 - 2026)

Cvs Health has reported Capital Expenditures for 18 years, with the latest figure at $849.0 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures rose 14.27% year-over-year to $849.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.9 billion (up 4.22% YoY), and the FY2025 full-year result was $2.8 billion, up 1.83% from the prior year.
• Capital Expenditures for Q1 2026 stood at $849.0 million, up from $784.0 million in the prior quarter.
• The five-year high for Capital Expenditures was $1.1 billion in Q1 2022, with the low at $408.0 million in Q2 2022.
• Historically, Capital Expenditures has averaged $718.8 million across 5 years, with a median of $698.0 million in 2025.
• Annual changes were most pronounced in 2023 — Capital Expenditures surged 44.85% — and 2024, when it declined 28.35%.
• Cvs Health's Capital Expenditures stood at $688.0 million in 2022, then jumped by 32.41% to $911.0 million in 2023, then decreased by 15.7% to $768.0 million in 2024, then grew by 2.08% to $784.0 million in 2025, then increased by 8.29% to $849.0 million in 2026.
• The last three Capital Expenditures figures came in at $849.0 million (Q1 2026), $784.0 million (Q4 2025), and $698.0 million (Q3 2025), per Business Quant data.